FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022005295> ?p ?o ?g. }

• W2022005295 endingPage "612" @default.
• W2022005295 startingPage "609" @default.
• W2022005295 abstract "The effects of primary and secondary long-term prophylaxis of Pneumocystis carinii pneumonia with aerosolized pentamidine on pulmonary function in HIV+ patients were evaluated. Eighty-one patients, none of whom were drug addicts or had pulmonary Kaposi's sarcoma, were studied. Fifty patients were receiving AP as secondary prophylaxis, 36 monthly and 14 twice-monthly; eight patients with a history of PCP served as control subjects. Twenty-three patients were receiving AP as primary prophylaxis, 12 monthly and 11 twice-monthly. Pulmonary function tests, including spirometry, lung transfer capacity for carbon monoxide (TLCO) and alveolar-arterial oxygen gradient (P[A-a]O2) were evaluated at M1, ie, one month after the diagnosis of PCP, or at the beginning of the AP prophylaxis, and then at three-month intervals (M4 to M13). No differences were observed in the results of spirometry or P(A-a)O2. Among the patients receiving secondary prophylaxis, a significant increase (paired Student's t-test) in TLCO occurred at M7 compared to M1 in the group receiving monthly administrations (p<0.01) and in the untreated control group (p<0.05); there was no significant difference in TLCO at M13 compared to M1 in the 12 patients who received monthly administrations for this period or at M7 in the 14 patients receiving AP twice-monthly. No significant difference in TLCO was observed at M7 in the primary prophylaxis groups. These results indicate that pulmonary tolerance of AP, as reflected by pulmonary function tests, is good. (Chest 1991; 99:609–12) The effects of primary and secondary long-term prophylaxis of Pneumocystis carinii pneumonia with aerosolized pentamidine on pulmonary function in HIV+ patients were evaluated. Eighty-one patients, none of whom were drug addicts or had pulmonary Kaposi's sarcoma, were studied. Fifty patients were receiving AP as secondary prophylaxis, 36 monthly and 14 twice-monthly; eight patients with a history of PCP served as control subjects. Twenty-three patients were receiving AP as primary prophylaxis, 12 monthly and 11 twice-monthly. Pulmonary function tests, including spirometry, lung transfer capacity for carbon monoxide (TLCO) and alveolar-arterial oxygen gradient (P[A-a]O2) were evaluated at M1, ie, one month after the diagnosis of PCP, or at the beginning of the AP prophylaxis, and then at three-month intervals (M4 to M13). No differences were observed in the results of spirometry or P(A-a)O2. Among the patients receiving secondary prophylaxis, a significant increase (paired Student's t-test) in TLCO occurred at M7 compared to M1 in the group receiving monthly administrations (p<0.01) and in the untreated control group (p<0.05); there was no significant difference in TLCO at M13 compared to M1 in the 12 patients who received monthly administrations for this period or at M7 in the 14 patients receiving AP twice-monthly. No significant difference in TLCO was observed at M7 in the primary prophylaxis groups. These results indicate that pulmonary tolerance of AP, as reflected by pulmonary function tests, is good. (Chest 1991; 99:609–12)" @default.
• W2022005295 created "2016-06-24" @default.
• W2022005295 creator A5013566909 @default.
• W2022005295 creator A5028889647 @default.
• W2022005295 creator A5042365101 @default.
• W2022005295 creator A5059196077 @default.
• W2022005295 creator A5081724059 @default.
• W2022005295 date "1991-03-01" @default.
• W2022005295 modified "2023-10-18" @default.
• W2022005295 title "Pulmonary Tolerance of Prophylactic Aerosolized Pentamidine in Human Immunodeficiency Virus-Infected Patients*" @default.
• W2022005295 cites W149202394 @default.
• W2022005295 cites W1507466615 @default.
• W2022005295 cites W1900639714 @default.
• W2022005295 cites W1966921061 @default.
• W2022005295 cites W1991848817 @default.
• W2022005295 cites W2017960619 @default.
• W2022005295 cites W2025967381 @default.
• W2022005295 cites W2108470804 @default.
• W2022005295 cites W2111449967 @default.
• W2022005295 cites W2152123040 @default.
• W2022005295 cites W2168853626 @default.
• W2022005295 cites W2324816636 @default.
• W2022005295 cites W3151303484 @default.
• W2022005295 doi "https://doi.org/10.1378/chest.99.3.609" @default.
• W2022005295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1995216" @default.
• W2022005295 hasPublicationYear "1991" @default.
• W2022005295 type Work @default.
• W2022005295 sameAs 2022005295 @default.
• W2022005295 citedByCount "9" @default.
• W2022005295 countsByYear W20220052952021 @default.
• W2022005295 crossrefType "journal-article" @default.
• W2022005295 hasAuthorship W2022005295A5013566909 @default.
• W2022005295 hasAuthorship W2022005295A5028889647 @default.
• W2022005295 hasAuthorship W2022005295A5042365101 @default.
• W2022005295 hasAuthorship W2022005295A5059196077 @default.
• W2022005295 hasAuthorship W2022005295A5081724059 @default.
• W2022005295 hasConcept C126322002 @default.
• W2022005295 hasConcept C141071460 @default.
• W2022005295 hasConcept C16020263 @default.
• W2022005295 hasConcept C165637977 @default.
• W2022005295 hasConcept C2776042228 @default.
• W2022005295 hasConcept C2776178081 @default.
• W2022005295 hasConcept C2777530519 @default.
• W2022005295 hasConcept C2777559004 @default.
• W2022005295 hasConcept C2777714996 @default.
• W2022005295 hasConcept C2777914695 @default.
• W2022005295 hasConcept C2780333948 @default.
• W2022005295 hasConcept C2993443204 @default.
• W2022005295 hasConcept C3018587741 @default.
• W2022005295 hasConcept C42219234 @default.
• W2022005295 hasConcept C71924100 @default.
• W2022005295 hasConcept C75603125 @default.
• W2022005295 hasConceptScore W2022005295C126322002 @default.
• W2022005295 hasConceptScore W2022005295C141071460 @default.
• W2022005295 hasConceptScore W2022005295C16020263 @default.
• W2022005295 hasConceptScore W2022005295C165637977 @default.
• W2022005295 hasConceptScore W2022005295C2776042228 @default.
• W2022005295 hasConceptScore W2022005295C2776178081 @default.
• W2022005295 hasConceptScore W2022005295C2777530519 @default.
• W2022005295 hasConceptScore W2022005295C2777559004 @default.
• W2022005295 hasConceptScore W2022005295C2777714996 @default.
• W2022005295 hasConceptScore W2022005295C2777914695 @default.
• W2022005295 hasConceptScore W2022005295C2780333948 @default.
• W2022005295 hasConceptScore W2022005295C2993443204 @default.
• W2022005295 hasConceptScore W2022005295C3018587741 @default.
• W2022005295 hasConceptScore W2022005295C42219234 @default.
• W2022005295 hasConceptScore W2022005295C71924100 @default.
• W2022005295 hasConceptScore W2022005295C75603125 @default.
• W2022005295 hasIssue "3" @default.
• W2022005295 hasLocation W20220052951 @default.
• W2022005295 hasLocation W20220052952 @default.
• W2022005295 hasOpenAccess W2022005295 @default.
• W2022005295 hasPrimaryLocation W20220052951 @default.
• W2022005295 hasRelatedWork W1836196174 @default.
• W2022005295 hasRelatedWork W1976102541 @default.
• W2022005295 hasRelatedWork W2012104029 @default.
• W2022005295 hasRelatedWork W2022005295 @default.
• W2022005295 hasRelatedWork W2035350579 @default.
• W2022005295 hasRelatedWork W2119968951 @default.
• W2022005295 hasRelatedWork W2142138195 @default.
• W2022005295 hasRelatedWork W2215316062 @default.
• W2022005295 hasRelatedWork W2885857296 @default.
• W2022005295 hasRelatedWork W4310552463 @default.
• W2022005295 hasVolume "99" @default.
• W2022005295 isParatext "false" @default.
• W2022005295 isRetracted "false" @default.
• W2022005295 magId "2022005295" @default.
• W2022005295 workType "article" @default.